AXS-14 (esreboxetine)

Drug identity checked against registry records

Also recorded as AXS-14; esreboxetine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-Label Safety Study of AXS-14 in Subjects With FibromyalgiaNCT07637162AXSMPhase 3Enrolling by invitation2028-05Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.